CatherineFWelshMD

PubMed

• 77 citations
  Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical...
  Alberto J. Montero, Claudia Marcela Diaz-Montero, Y. E. Deutsch, Judith Hurley, Leonidas G. Koniaris, T. Rumboldt, S. Yasir, M. Jorda, E. Garret-Mayer, Eli Avisar, Joy...> ;Breast Cancer Research and Treatment. 2012 Feb 1
• 58 citations
  Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
  C. Lobo, Gilberto Lopes, Odalys Baez, Aurelio Castrellon, Annapoorna Ferrell, Connie Higgins, Erin Hurley, Judith Hurley, Isildinha Reis, Stephen P. Richman, Pearl Seo...> ;Breast Cancer Research and Treatment. 2010 Jun 29
• Neoadjuvant dose-dense docetaxel, carboplatinum, and trastuzumab (ddTCH) chemotherapy for HER2 overexpressing breast cancer.
  Bayraktar S, Bayraktar UD, Reis IM, Pegram M, Welsh C, Silva O, Franchesci D, Gomez CR, Hurley J> ;J. Clin. Oncol.. 2009-05-20
• Neoadjuvant platinum-based chemotherapy (CT) for triple-negative locally advanced breast cancer (LABC): Retrospective analysis of 125 patients.
  Leone JP, Guardiola V, Venkatraman A, Pegram MD, Welsh C, Silva O, Larrieux R, Franchesci D, Gomez C, Hurley J> ;J. Clin. Oncol.. 2009-05-20
• Phase II study of nab-paclitaxel, bevacizumab, and gemcitabine for first-line therapy of patients with HER2-negative metastatic breast cancer (MBC).
  Gluck S, Lobo C, Reis I, Lopes G, Carmody C, Tukia K, Hurley J, Seo P, Silva O, Slingerland J, Welsh C> ;J. Clin. Oncol.. 2008-05-20
• 10 citations
  A Phase II trial of split, low-dose docetaxel and low-dose capecitabine: a tolerable and efficacious regimen in the first-line treatment of patients with HER2/neu-nega...
  Orlando Silva, Gilberto Lopes, Daniel Morgenzstern, C. Lobo, Philomena Doliny, Edgardo S. Santos, Sakher Abdullah, Umang Gautam, Isildinha Reis, Catherine F. Welsh, Jo...> ;Clinical Breast Cancer. 2008 Apr 1
• Split, low-dose docetaxel (D) and low-dose capecitabine (C) is an active regimen in metastatic breast cancer with minimal toxicity.
  Silva OE, Lopes G, Morgensztern D, Lobo C, Abdullah S, Doliny P, Slingerland J, Gluck S, Santos E, Welsh C, Hurley J> ;J. Clin. Oncol.. 2006-06-20
• 23 citations
  Methodology for preservation of high molecular-weight RNA in paraffin-embedded tissue: application for laser-capture microdissection.
  Vladimir Vincek, Mehdi Nassiri, Norman L. Block, Catherine F Welsh, Mehrdad Nadji, Azorides R. Morales> ;Diagnostic Molecular Pathology. 2005 Sep 1
• 9 citations
  Weekly docetaxel/carboplatin as primary systemic therapy for HER2-negative locally advanced breast cancer.
  Judith Hurley, Isildinha M. Reis, Orlando Silva, Carmen Gomez, Fernando DeZarraga, Pedro Velez, Catherine F. Welsh, Jodeen Powell, Philomena Doliny> ;Clinical Breast Cancer. 2005 Feb 1
• 35 citations
  Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21(CIP1) levels in androgen-independent human prostate cancer cells.
  Selena Knight-Krajewski, Catherine F. Welsh, YunQi Liu, Leah S. Lyons, Joanne M. Faysal, Eddy S. Yang, Kerry L. Burnstein> ;Oncogene. 2004 Jul 15
• 50 citations
  Rho GTPases as key transducers of proliferative signals in g1 cell cycle regulation.
  Catherine F. Welsh> ;Breast Cancer Research and Treatment. 2004 Mar 1
• 251 citations
  Timing of cyclin D1 expression within G1 phase is controlled by Rho
  Catherine F. Welsh, Kristin Roovers, Jessie Villanueva, Yun Qi Liu, Martin A. Schwartz, Richard K. Assoian> ;Nature Cell Biology. 2001 Nov 1
• 24 citations
  A growing role for Rho family GTPases as intermediaries in growth factor- and adhesion-dependent cell cycle progression.
  Catherine F. Welsh, Richard K. Assoian> ;Biochimica Et Biophysica Acta. 2000 Jul 31
• 42 citations
  Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis
  Lilly Y.W. Bourguignon, Naoko Iida, Catherine F. Welsh, Dan Zhu, Arnon Krongrad, David Pasquale> ;Journal of Neuro-Oncology. 1995 Dec 1
• 40 citations
  Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells
  Catherine F. Welsh, Dan Zhu, Lilly Y.W. Bourguignon> ;Journal of Cellular Physiology. 1995 Sep 1
• 41 citations
  ADP-ribosylation factors: a family of approximately 20-kDa guanine nucleotide-binding proteins that activate cholera toxin.
  Catherine F. Welsh, Joel Moss, Martha Vaughan> ;Molecular and Cellular Biochemistry. 1994 Sep 1
• 11 citations
  Isolation of recombinant ADP-ribosylation factor 6, an approximately 20-kDa guanine nucleotide-binding protein, in an activated GTP-bound state.
  Catherine F. Welsh, Joel Moss, Martha Vaughan> ;The Journal of Biological Chemistry. 1994 Jun 3
• 6 citations
  Activation of Cholera Toxin by ADP-Ribosylation Factors: 20-kDa Guanine Nucleotide-Binding Proteins.
  Joel Moss, R. S. Haun, Su-Chen Tsai, Catherine F. Welsh, Fang-Jen S. Lee, S R Price, Martha Vaughan> ;Methods in Enzymology. 1994 Jan 1
• 6 citations
  Characterization of recombinant and endogenous ADP-ribosylation factors synthesized in Sf9 insect cells
  Barbara C. Kunz, Kimberly A. Muczynski, Catherine F. Welsh, S J Stanley, Su Chen Tsai, Ronald Adamik, Patrick P. Chang, Joel Moss, Martha Vaughan> ;Biochemistry. 1993 Jul 6
• 32 citations
  Effects of phospholipid and GTP on recombinant ADP-ribosylation factors (ARFs). Molecular basis for differences in requirements for activity of mammalian ARFs.
  S R Price, Catherine F. Welsh, R. S. Haun, S J Stanley, Joel Moss, Martha Vaughan> ;The Journal of Biological Chemistry. 1992 Sep 5
• ADP-ribosylation factor, a guanine nucleotide-binding protein activator of cholera toxin, is isolated in an activated state when expressed as a fusion protein in Esche...
  Catherine F. Welsh, Joel Moss, Martha Vaughan> ;Transactions of the Association of American Physicians. 1992 Jan 1
• 52 citations
  Relationship between phospholipase C activation and prostaglandin E2 and cyclic adenosine monophosphate production in rabbit tubular epithelial cells. Effects of angio...
  Catherine F. Welsh, George R. Dubyak, J G Douglas> ;The Journal of Clinical Investigation. 1988 Mar 1
• Collagen heterogeneity in normal rabbit cornea. I. Isolation and biochemical characterization of the genetically-distinct collagens.
  Welsh C, Gay S, Rhodes RK, Pfister R, Miller EJ> ;Biochim. Biophys. Acta. 1980-09-23
• Join now to see all